Invesco Ltd. - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$92,152
-10.4%
53,577
+1.6%
0.00%
Q2 2023$102,813
+80.4%
52,725
+279.7%
0.00%
Q1 2022$57,000
-99.4%
13,885
-98.1%
0.00%
-100.0%
Q4 2021$9,576,000
+114.7%
744,600
+80.3%
0.00%
+100.0%
Q3 2021$4,460,000
+139.0%
412,938
+102.0%
0.00%
Q2 2021$1,866,000204,4220.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders